Sign in

CIK 0000318154

  • Large accelerated filer
Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
953540776
Phone
+1 805-447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-05-19 Garland Greg C. Director Grant or award +665 13,848
2025-05-23 Garland Greg C. Director Grant or award +809 13,183
2024-05-31 Garland Greg C. Director Grant or award +719 12,374
2023-05-19 Garland Greg C. Director Grant or award +939 11,655
2022-05-17 Garland Greg C. Director Grant or award +855 10,716
2021-05-18 Garland Greg C. Director Grant or award +837 9,861

Page 1 of 1 · 6 trades